专题:Lung Cancer Diagnosis and Treatment

This cluster of papers focuses on the diagnosis and treatment of lung cancer, including topics such as CT screening, radiotherapy, chemotherapy, tumor staging, adjuvant therapy, positron emission tomography, stereotactic body radiation therapy, non-small cell lung cancer, and pulmonary nodules.
最新文献
Left Lung Ultracentral, Radioresistant Metastasis: A Double Dilemma

article Full Text OpenAlex

An integrated deep learning framework leveraging NASNet and vision transformer with MixProcessing for accurate and precise diagnosis of lung diseases

article Full Text OpenAlex

CCEMSS ‐Unet++: An Enhanced Multi‐Scale Context Fusion Network for Pulmonary Nodule Segmentation

article Full Text OpenAlex

European Code Against Cancer, 5th edition – organised cancer screening programmes

article Full Text OpenAlex

PET/CT-guided management of immune checkpoint blockade and multi-modal profiling following treatment in long-term responders with metastatic lung cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM)

article Full Text OpenAlex

A Comprehensive Study of Various Hybrid Deep Learning Models for Automated and Explainable Pneumonia Detection in the Pulmonary Alveolar Region: Current Insights and Future Directions

article Full Text OpenAlex

Monitoring the Harms of Lung Cancer Screening: Why the Nonmalignant Resection Rate Is Our Best Bet

article Full Text OpenAlex

Impact of Baseline Body Mass Index on Immunotherapy Outcomes in Patients With Non-small-cell Lung Cancer

article Full Text OpenAlex

Third‐Generation EGFRTKIs Combined With Chemotherapy in Advanced Non‐Small Cell Lung Cancer: A Real‐World Study

article Full Text OpenAlex

Cerebrospinal Fluid Metabolomics and Machine Learning Identify Novel Biomarkers for Lung Cancer Leptomeningeal Metastasis

article Full Text OpenAlex

近5年高被引文献
Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer

article Full Text OpenAlex 2350 FWCI233.3462

Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial

article Full Text OpenAlex 1542 FWCI226.1601

The global burden of lung cancer: current status and future trends

review Full Text OpenAlex 1223 FWCI323.9207

Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer

article Full Text OpenAlex 1194 FWCI171.2031

Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer

article Full Text OpenAlex 923 FWCI216.0855

Lobar or Sublobar Resection for Peripheral Stage IA Non–Small-Cell Lung Cancer

article Full Text OpenAlex 919 FWCI242.6127

Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

article Full Text OpenAlex 709 FWCI185.697

Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB–IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial

article Full Text OpenAlex 704 FWCI70.9527

Non–Small Cell Lung Cancer, Version 4.2024

article Full Text OpenAlex 636 FWCI251.1455

Non‐small cell lung cancer in China

review Full Text OpenAlex 612 FWCI86.6339